The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Helen E Jo*1
- Jyotika D Prasad*2,3
- Lauren K Troy1
- Annabelle Mahar1
- Jane Bleasel4
- Samantha J Ellis2
- Daniel C Chambers5,6
- Anne E Holland2,7
- Fiona R Lake8
- Gregory Keir9
- Nicole S Goh10
- Margaret Wilsher11,12
- Sally de Boer13
- Yuben Moodley8
- Christopher Grainge14
- Helen M Whitford2
- Sally A Chapman15
- Paul N Reynolds15
- David Beatson**16
- Leonie J Jones14
- Peter Hopkins17
- Heather M Allan18
- Ian Glaspole***2,19
- Tamera J Corte***1
- 1 Royal Prince Alfred Hospital, Sydney, NSW
- 2 Alfred Hospital, Melbourne, VIC
- 3 Royal Melbourne Hospital, Melbourne, VIC
- 4 University of Sydney, Sydney, NSW
- 5 University of Queensland, Brisbane, QLD
- 6 Prince Charles Hospital, Brisbane, QLD
- 7 La Trobe University, Melbourne, VIC
- 8 University of Western Australia, Perth, WA
- 9 Princess Alexandra Hospital, Brisbane, QLD
- 10 Austin Health, Melbourne, VIC
- 11 Auckland District Health Board, Auckland, NZ
- 12 University of Auckland, Auckland, NZ
- 13 Auckland City Hospital, Auckland, NZ
- 14 John Hunter Hospital, Newcastle, NSW
- 15 Royal Adelaide Hospital, Adelaide, SA
- 16 Auckland, NZ
- 17 Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, QLD
- 18 Lung Foundation Australia, Brisbane, QLD
- 19 Monash University, Melbourne, VIC
* Joint first authors
** Deceased
*** Joint senior authors
David Beatson was a well known New Zealand journalist, broadcaster and editor. Among his many roles, he served as Prime Minister’s chief press officer, and chair of NZ on Air. A thoughtful, erudite and engaging patient, David died from IPF on 21 September 2017. We acknowledge his important contribution as patient author on this article.
For competing interest declarations, see online .
Abstract
Introduction: Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease associated with debilitating symptoms of dyspnoea and cough, resulting in respiratory failure, impaired quality of life and ultimately death. Diagnosing IPF can be challenging, as it often shares many features with other interstitial lung diseases. In this article, we summarise recent joint position statements on the diagnosis and management of IPF from the Thoracic Society of Australia and New Zealand and Lung Foundation Australia, specifically tailored for physicians across Australia and New Zealand.
Main suggestions: